Financial Snapshot

Revenue
$1.139B
TTM
Gross Margin
21.66%
TTM
Net Earnings
$57.27M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
262.05%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$434.9M
Q3 2024
Cash
Q3 2024
P/E
22.12
Nov 29, 2024 EST
Free Cash Flow
$160.4M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017
Revenue $1.089B $786.9M $500.6M $344.9M $229.7M $105.4M $48.60M
YoY Change 38.34% 57.19% 45.17% 50.15% 117.92% 116.87%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017
Revenue $1.089B $786.9M $500.6M $344.9M $229.7M $105.4M $48.60M
Cost Of Revenue $849.8M $619.6M $388.5M $274.8M $184.2M $86.00M $41.20M
Gross Profit $238.8M $167.3M $112.1M $70.06M $45.51M $19.40M $7.400M
Gross Profit Margin 21.94% 21.26% 22.4% 20.32% 19.81% 18.41% 15.23%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017
Selling, General & Admin $176.6M $144.0M $79.80M $61.71M $35.83M $22.90M $18.40M
YoY Change 22.66% 80.44% 29.3% 72.24% 56.45% 24.46%
% of Gross Profit 73.96% 86.05% 71.16% 88.08% 78.73% 118.04% 248.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.281M $1.601M $1.301M $1.906M $2.133M $1.880M $1.560M
YoY Change 42.47% 23.06% -31.74% -10.64% 13.46% 20.51%
% of Gross Profit 0.96% 0.96% 1.16% 2.72% 4.69% 9.69% 21.08%
Operating Expenses $176.6M $144.0M $79.80M $61.71M $35.83M $22.90M $18.40M
YoY Change 22.66% 80.44% 29.3% 72.24% 56.45% 24.46%
Operating Profit $62.18M $23.34M $32.34M $8.348M $9.677M -$3.500M -$11.00M
YoY Change 166.42% -27.83% 287.4% -13.73% -376.49% -68.18%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017
Interest Expense $3.304M $814.0K $461.0K $100.0K -$100.0K -$500.0K -$700.0K
YoY Change 305.9% 76.57% 361.0% -200.0% -80.0% -28.57%
% of Operating Profit 5.31% 3.49% 1.43% 1.2% -1.03%
Other Income/Expense, Net $8.507M $1.100M $95.00K $331.0K -$18.23M -$2.900M -$700.0K
YoY Change 673.36% 1057.89% -71.3% -101.82% 528.76% 314.29%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017
Pretax Income $70.69M $24.44M $32.44M $8.679M -$8.557M -$6.900M -$12.50M
YoY Change 189.23% -24.65% 273.72% -201.43% 24.01% -44.8%
Income Tax $8.654M -$5.917M -$33.33M -$37.78M $12.00K -$1.800M $0.00
% Of Pretax Income 12.24% -24.21% -102.77% -435.3%
Net Earnings $62.04M $30.36M $65.77M $46.46M -$8.569M $700.0K -$12.50M
YoY Change 104.35% -53.84% 41.56% -642.18% -1324.14% -105.6%
Net Earnings / Revenue 5.7% 3.86% 13.14% 13.47% -3.73% 0.66% -25.72%
Basic Earnings Per Share $0.65 $0.33 $0.74 $0.54 -$0.41
Diluted Earnings Per Share $0.62 $0.30 $0.66 $0.47 -$0.41 $8.516K -$152.1K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017
Cash & Short-Term Investments $371.1M $189.3M $119.4M $109.3M $80.40M $100.0K $4.700M
YoY Change 96.03% 58.52% 9.26% 35.95% 80300.0% -97.87%
Cash & Equivalents $97.30M $120.1M $91.41M $70.30M $80.40M $100.0K $4.700M
Short-Term Investments $273.8M $69.22M $28.01M $39.00M
Other Short-Term Assets $27.45M $4.489M $4.564M $5.300M $5.000M $1.100M $700.0K
YoY Change 511.52% -1.64% -13.89% 6.0% 354.55% 57.14%
Inventory
Prepaid Expenses
Receivables $241.9M $240.1M $134.6M $75.70M $47.10M $23.30M $11.40M
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $640.4M $433.9M $258.5M $190.2M $132.4M $24.50M $16.80M
YoY Change 47.61% 67.81% 35.93% 43.66% 440.41% 45.83%
Property, Plant & Equipment $27.82M $15.27M $12.83M $12.10M $3.100M $800.0K $600.0K
YoY Change 82.13% 19.03% 6.05% 290.32% 287.5% 33.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $76.52M $81.88M $74.22M $38.50M $700.0K $300.0K $400.0K
YoY Change -6.55% 10.32% 92.77% 5400.0% 133.33% -25.0%
Total Long-Term Assets $116.2M $109.1M $99.53M $63.70M $18.00M $16.80M $18.20M
YoY Change 6.49% 9.65% 56.24% 253.89% 7.14% -7.69%
Total Assets $756.6M $543.0M $358.1M $253.9M $150.4M $41.30M $35.00M
YoY Change
Accounts Payable $125.4M $109.3M $61.40M $43.50M $19.40M $15.60M $5.100M
YoY Change 14.77% 77.99% 41.15% 124.23% 24.36% 205.88%
Accrued Expenses $60.52M $43.77M $35.25M $30.40M $14.90M $9.400M $7.100M
YoY Change 38.28% 24.16% 15.96% 104.03% 58.51% 32.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $300.0K $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00 $3.600M
YoY Change -100.0%
Total Short-Term Liabilities $186.0M $159.5M $98.82M $77.80M $36.20M $30.20M $17.80M
YoY Change 16.56% 61.43% 27.02% 114.92% 19.87% 69.66%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.600M
YoY Change -100.0%
Other Long-Term Liabilities $17.24M $6.482M $7.419M $9.200M $0.00 $4.900M
YoY Change 165.98% -12.63% -19.36% -100.0%
Total Long-Term Liabilities $17.24M $6.482M $7.419M $9.200M $0.00 $0.00 $6.500M
YoY Change 165.98% -12.63% -19.36% -100.0%
Total Liabilities $203.2M $166.0M $106.2M $87.00M $36.20M $30.20M $24.30M
YoY Change 22.39% 56.26% 22.12% 140.33% 19.87% 24.28%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017
Basic Shares Outstanding 95.02M shares 92.20M shares 89.11M 85.72M 20.74M
Diluted Shares Outstanding 100.7M shares 99.96M shares 100.4M 99.06M 20.74M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.2671 Billion

About Progyny, Inc.

Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 563 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. The company has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The firm provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. The company provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Industry: Services-Misc Health & Allied Services, NEC Peers: Alignment Healthcare, Inc. Elevance Health, Inc. CENTENE CORP CLOVER HEALTH INVESTMENTS, CORP. /DE HEALTHEQUITY, INC. HUMANA INC MOLINA HEALTHCARE, INC. PACIFIC HEALTH CARE ORGANIZATION INC UNITEDHEALTH GROUP INC